AAVantgarde appoints Mr. Rasmus HolmJorgensen as Chief Financial Officer
News Source : Financial Post
News Summary
- AAVantgarde Bio has announced the appointment of Rasmus Holm-Jorgesen as their Chief Financial Officer (CFO) Rasmus brings over 25 years of experience in strategy, finance and global operations within the biopharmaceutical industry
- He was part of the founding team for Kiniksa Pharmaceuticals, where he held the role of Chief Strategy and Portfolio Officer from 2015 to 2022
MILAN, April 28, 2025 (GLOBE NEWSWIRE) AAVantgarde Bio (AAVantgarde), a clinicalstage, international biotechnology company with two proprietary AdenoAssociated Viral (AAV) vector platforms for larg [+4348 chars]